Impact of high-throughput screening in biomedical research
Knowledge Source Identification | |
---|---|
Knowledge source name | Impact of high-throughput screening in biomedical research |
Owner/Developer | Nature Reviews Drug Discovery |
Country | United States of America |
Languages | English |
URL | http://www.nature.com/nrd/journal/v10/n3/full/nrd3368.html |
Description | High-throughput screening (HTS) has been postulated in several quarters to be a contributory factor to the decline in productivity in the pharmaceutical industry. Moreover, it has been blamed for stifling the creativity that drug discovery demands. In this article, we aim to dispel these myths and present the case for the use of HTS as part of a proven scientific tool kit, the wider use of which is essential for the discovery of new chemotypes. |
Knowledge Source Category | |
Category | Publication |
Sub categories | Review / Research article |
Knowledge Dissemination and Sharing | |
Dissemination channel | Website |
Targeted audience (specified/objective analysis) | Scientists, Students, Industry, Researchers |
Users access | Restricted access, Fee-based access |
Knowledge Characterization | |
3Rs relevance | Replacement, Reduction |
Purpose | Method development, Fundamental studies, Documentation and information |
Technology/Tools | High throughput screening, High content screening |